(TheNewswire)
Vancouver, BC - TheNewswire - January 31, 2023 - Solarvest BioEnergy Inc. (“ Solarvest ”, or the “ Company ”) (TSXV:SVS) , announces that Leslie Auld has beenappointed the company’s Chief Financial Officer effective January30, 2023.
Leslie Auld is a seasonedFinancial Executive with over 30 years of relevant experience,including a background in Canadian and U.S. publicly listed companiesin the pharmaceutical and diagnostic technology industries. She hasheld executive positions in biotechnology companies including Aeterna Zentaris and mostrecently as CFO of Tetra Bio-Pharma.
Ms. Auld is an experienced financial executive withextensive biotech experience. She is a CPA in Canada and holds a H.BSc., in Pharmacology and Toxicology from Western University and anMBA from the University of Toronto – Rotman School ofManagement.
Claes Ellegaard, CEO of Solarvest says “Leslie is ananalytical, strategic, and solutions-oriented finance professional,who will bring a lot of expertise and experience to our organizationand I’m very pleased that Leslie will join our team.”
Mr. Ellegaard continues “Leslie will workhand-in-hand with Gerard Watts, who up till now has been acting asSolarvest’s interim CFO. We are very grateful that Gerard willcontinue being part of the organization in this important transitionphase where his experience will be invaluable”.
Solarvest invite all shareholders to a corporate updatemeeting hosted on Zoom Wednesday February 8, 2023 at 4.15 pm EST.Please use following zoom link to participate in the call: https://zoom.us/j/92930790470
AboutSolarvest
Solarvest BioEnergy Inc. is an algae biologics companywhose production platform provides it with an extremely flexiblesystem capable of producing numerous products from Omega 3 fatty acidsto human therapeutic proteins.
For further information contact:
Claes Ellegaard
Phone: 1.514.898.3488
Email: invest@solarvest.ca
Forward-LookingInformation
This press release contains “forward-lookinginformation” within the meaning of applicable Canadian securitieslegislation. Forward-looking information includes, but is not limitedto, statements with respect to the terms of the Offering, thecompletion of the Offering and the expected use of the net proceedsreceived by the Company. Generally, forward-looking information can beidentified by the use of forward-looking terminology such as“plans”, “expects” or “does not expect”, “isexpected”, “budget”, “scheduled”, “estimates”,“forecasts”, “intends”, “anticipates” or “does notanticipate”, or “believes”, or variations of such words andphrases or state that certain actions, events or results “may”,“could”, “would”, “might” or “will be taken”,“occur” or “be achieved”. Forward-looking information issubject to known and unknown risks, uncertainties and other factorsthat may cause the actual results, level of activity, performance orachievements of the Company to be materially different from thoseexpressed or implied by such forward-looking information, includingbut not limited to: general business, economic, competitive,geopolitical and social uncertainties; and regulatory risks. Althoughthe Company has attempted to identify important factors that couldcause actual results to differ materially from those contained inforward-looking information, there may be other factors that causeresults not to be as anticipated, estimated or intended. There can beno assurance that such information will prove to be accurate, asactual results and future events could differ materially from thoseanticipated in such statements. Accordingly, readers should not placeundue reliance on forward-looking information. The forward-lookinginformation contained in this news release is expressly qualified inits entirety by this cautionary statement. The Company does notundertake to update any forward-looking information, except asrequired by applicable securities laws.
Neither the TSXVenture Exchange nor its regulation services provider (as that term isdefined in the policies of the TSX Venture Exchange) acceptsresponsibility for the adequacy or accuracy of this pressrelease.
None of thesecurities of Solarvest have been registered under the U.S. SecuritiesAct of 1933, as amended (the “U.S. Securities Act”), or any statesecurities law, and may not be offered or sold in the United States orto, or for the account or benefit of, persons in the United States or“U.S. persons” (as such term is defined in Regulation S under theU.S. Securities Act) absent registration or an exemption from suchregistration requirements. This press release shall not constitute anoffer to sell or the solicitation of an offer to buy in the UnitedStates nor shall there be any sale of the securities in any State inwhich such offer, solicitation or sale would be unlawful.
Copyright (c) 2023 TheNewswire - All rights reserved.